These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38925569)

  • 1. Latrophilin-3 as a downstream effector of the androgen receptor induces urothelial tumorigenesis.
    Goto T; Yasui M; Teramoto Y; Nagata Y; Mizushima T; Miyamoto H
    Mol Carcinog; 2024 Oct; 63(10):1847-1854. PubMed ID: 38925569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Latrophilin-3 as a downstream effector of the androgen receptor induces bladder cancer progression.
    Goto T; Teramoto Y; Nagata Y; Miyamoto H
    Discov Oncol; 2024 Sep; 15(1):440. PubMed ID: 39269616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Latrophilins as Downstream Effectors of Androgen Receptors including a Splice Variant, AR-V7, Induce Prostate Cancer Progression.
    Teramoto Y; Elahi Najafi MA; Matsukawa T; Sharma A; Goto T; Miyamoto H
    Int J Mol Sci; 2024 Jul; 25(13):. PubMed ID: 39000396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear Factor-κB Promotes Urothelial Tumorigenesis and Cancer Progression via Cooperation with Androgen Receptor Signaling.
    Inoue S; Ide H; Mizushima T; Jiang G; Netto GJ; Gotoh M; Miyamoto H
    Mol Cancer Ther; 2018 Jun; 17(6):1303-1314. PubMed ID: 29592878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of glucocorticoid signaling in urothelial tumorigenesis: Inhibition by prednisone presumably through inducing glucocorticoid receptor transrepression.
    Ide H; Inoue S; Mizushima T; Kashiwagi E; Zheng Y; Miyamoto H
    Mol Carcinog; 2019 Dec; 58(12):2297-2305. PubMed ID: 31535408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased tumorigenesis and mortality from bladder cancer in mice lacking urothelial androgen receptor.
    Hsu JW; Hsu I; Xu D; Miyamoto H; Liang L; Wu XR; Shyr CR; Chang C
    Am J Pathol; 2013 May; 182(5):1811-20. PubMed ID: 23499463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ELK1 promotes urothelial tumorigenesis in the presence of an activated androgen receptor.
    Inoue S; Ide H; Mizushima T; Jiang G; Kawahara T; Miyamoto H
    Am J Cancer Res; 2018; 8(11):2325-2336. PubMed ID: 30555747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FOXO1 as a tumor suppressor inactivated via AR/ERβ signals in urothelial cells.
    Ide H; Mizushima T; Jiang G; Goto T; Nagata Y; Teramoto Y; Inoue S; Li Y; Kashiwagi E; Baras AS; Netto GJ; Kawahara T; Miyamoto H
    Endocr Relat Cancer; 2020 Apr; 27(4):231-244. PubMed ID: 32031965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FLRT proteins are endogenous latrophilin ligands and regulate excitatory synapse development.
    O'Sullivan ML; de Wit J; Savas JN; Comoletti D; Otto-Hitt S; Yates JR; Ghosh A
    Neuron; 2012 Mar; 73(5):903-10. PubMed ID: 22405201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compound A inhibits urothelial tumorigenesis via both the androgen receptor and glucocorticoid receptor signaling pathways.
    Ide H; Inoue S; Mizushima T; Jiang G; Nagata Y; Goto T; Kashiwagi E; Miyamoto H
    Am J Transl Res; 2020; 12(5):1779-1788. PubMed ID: 32509176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ELK1 is up-regulated by androgen in bladder cancer cells and promotes tumor progression.
    Kawahara T; Shareef HK; Aljarah AK; Ide H; Li Y; Kashiwagi E; Netto GJ; Zheng Y; Miyamoto H
    Oncotarget; 2015 Oct; 6(30):29860-76. PubMed ID: 26342199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD24 expression is important in male urothelial tumorigenesis and metastasis in mice and is androgen regulated.
    Overdevest JB; Knubel KH; Duex JE; Thomas S; Nitz MD; Harding MA; Smith SC; Frierson HF; Conaway M; Theodorescu D
    Proc Natl Acad Sci U S A; 2012 Dec; 109(51):E3588-96. PubMed ID: 23012401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin Inhibits Chemical Carcinogen-mediated Malignant Transformation of Urothelial Cells:
    Nagata Y; Quynh NT; Aono H; Harada K; Miyamoto H; Fujimoto N
    Cancer Genomics Proteomics; 2024; 21(4):388-394. PubMed ID: 38944424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the androgen receptor in urothelial cancer.
    Inoue S; Mizushima T; Miyamoto H
    Mol Cell Endocrinol; 2018 Apr; 465():73-81. PubMed ID: 28652170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conditional Expression of the Androgen Receptor Increases Susceptibility of Bladder Cancer in Mice.
    Johnson DT; Hooker E; Luong R; Yu EJ; He Y; Gonzalgo ML; Sun Z
    PLoS One; 2016; 11(2):e0148851. PubMed ID: 26862755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective role of mineralocorticoid receptor signaling in urothelial tumorigenesis.
    Nagata Y; Matsukawa T; Goto T; Teramoto Y; Jiang G; Fujimoto N; Miyamoto H
    Am J Cancer Res; 2023; 13(2):408-418. PubMed ID: 36895984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constitutive β-catenin activation induces male-specific tumorigenesis in the bladder urothelium.
    Lin C; Yin Y; Stemler K; Humphrey P; Kibel AS; Mysorekar IU; Ma L
    Cancer Res; 2013 Oct; 73(19):5914-25. PubMed ID: 23928991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen receptor signals regulate UDP-glucuronosyltransferases in the urinary bladder: a potential mechanism of androgen-induced bladder carcinogenesis.
    Izumi K; Zheng Y; Hsu JW; Chang C; Miyamoto H
    Mol Carcinog; 2013 Feb; 52(2):94-102. PubMed ID: 22086872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzalutamide as an androgen receptor inhibitor prevents urothelial tumorigenesis.
    Kawahara T; Inoue S; Kashiwagi E; Chen J; Ide H; Mizushima T; Li Y; Zheng Y; Miyamoto H
    Am J Cancer Res; 2017; 7(10):2041-2050. PubMed ID: 29119053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporine A and tacrolimus inhibit urothelial tumorigenesis.
    Kawahara T; Kashiwagi E; Li Y; Zheng Y; Miyamoto Y; Netto GJ; Ishiguro H; Miyamoto H
    Mol Carcinog; 2016 Feb; 55(2):161-9. PubMed ID: 25594762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.